Cytosorbents Corporation (CTSO)
USD 1.0
(1.18%)
USD 1.0
(1.18%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 22.39 Million USD | 45.36% |
| 2022 | 15.4 Million USD | -46.99% |
| 2021 | 29.06 Million USD | 2.33% |
| 2020 | 28.4 Million USD | 84.39% |
| 2019 | 15.4 Million USD | 20.68% |
| 2018 | 12.76 Million USD | 62.31% |
| 2017 | 7.86 Million USD | 84.92% |
| 2016 | 4.25 Million USD | 130.7% |
| 2015 | 1.84 Million USD | 82.32% |
| 2014 | 1.01 Million USD | 192.77% |
| 2013 | -1.08 Million USD | -549.74% |
| 2012 | -167.72 Thousand USD | -789.71% |
| 2011 | 24.31 Thousand USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 6.57 Million USD | 23.71% |
| 2024 Q2 | 6.5 Million USD | -1.03% |
| 2023 Q4 | 5.31 Million USD | 16.73% |
| 2023 Q2 | 4.67 Million USD | 19.26% |
| 2023 Q1 | 3.91 Million USD | -2.31% |
| 2023 Q3 | 4.55 Million USD | -2.57% |
| 2023 FY | 22.39 Million USD | 45.36% |
| 2022 Q3 | 1.96 Million USD | -47.92% |
| 2022 Q4 | 4 Million USD | 103.61% |
| 2022 Q2 | 3.78 Million USD | -33.06% |
| 2022 FY | 15.4 Million USD | -46.99% |
| 2022 Q1 | 5.64 Million USD | -14.12% |
| 2021 Q4 | 6.57 Million USD | 2.11% |
| 2021 FY | 29.06 Million USD | 2.33% |
| 2021 Q1 | 7.39 Million USD | -17.9% |
| 2021 Q2 | 8.65 Million USD | 17.09% |
| 2021 Q3 | 6.43 Million USD | -25.61% |
| 2020 Q1 | 5.77 Million USD | 27.8% |
| 2020 Q2 | 6.27 Million USD | 8.66% |
| 2020 Q4 | 9 Million USD | 22.41% |
| 2020 Q3 | 7.35 Million USD | 17.29% |
| 2020 FY | 28.4 Million USD | 84.39% |
| 2019 Q1 | 2.83 Million USD | -16.22% |
| 2019 FY | 15.4 Million USD | 20.68% |
| 2019 Q2 | 4.01 Million USD | 41.51% |
| 2019 Q3 | 4.03 Million USD | 0.4% |
| 2019 Q4 | 4.51 Million USD | 12.0% |
| 2018 Q1 | 2.86 Million USD | -5.46% |
| 2018 Q2 | 3.45 Million USD | 20.73% |
| 2018 FY | 12.76 Million USD | 62.31% |
| 2018 Q3 | 3.05 Million USD | -11.84% |
| 2018 Q4 | 3.38 Million USD | 11.07% |
| 2017 Q3 | 1.93 Million USD | 23.91% |
| 2017 FY | 7.86 Million USD | 84.92% |
| 2017 Q1 | 1.34 Million USD | 1.97% |
| 2017 Q2 | 1.55 Million USD | 16.2% |
| 2017 Q4 | 3.03 Million USD | 56.9% |
| 2016 Q2 | 979.4 Thousand USD | 25.9% |
| 2016 Q1 | 777.95 Thousand USD | 12.46% |
| 2016 FY | 4.25 Million USD | 130.7% |
| 2016 Q4 | 1.31 Million USD | 11.57% |
| 2016 Q3 | 1.17 Million USD | 20.4% |
| 2015 Q4 | 691.73 Thousand USD | 59.89% |
| 2015 FY | 1.84 Million USD | 82.32% |
| 2015 Q3 | 432.62 Thousand USD | 35.68% |
| 2015 Q2 | 318.85 Thousand USD | -20.29% |
| 2015 Q1 | 400.01 Thousand USD | -26.51% |
| 2014 Q3 | 558.37 Thousand USD | 133681.34% |
| 2014 Q2 | -418.00 USD | 99.54% |
| 2014 Q1 | -91.62 Thousand USD | 82.5% |
| 2014 FY | 1.01 Million USD | 192.77% |
| 2014 Q4 | 544.34 Thousand USD | -2.51% |
| 2013 Q4 | -523.71 Thousand USD | -25.57% |
| 2013 Q1 | -77.41 Thousand USD | 88.0% |
| 2013 Q2 | -71.58 Thousand USD | 7.53% |
| 2013 Q3 | -417.06 Thousand USD | -482.6% |
| 2013 FY | -1.08 Million USD | -549.74% |
| 2012 FY | -167.72 Thousand USD | -789.71% |
| 2012 Q1 | 6813.00 USD | -71.98% |
| 2012 Q3 | 463.49 Thousand USD | 1918.54% |
| 2012 Q2 | 22.96 Thousand USD | 237.03% |
| 2012 Q4 | -645.23 Thousand USD | -239.21% |
| 2011 Q4 | 24.31 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | 24.31 Thousand USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 100.0% |
| 2006 Q4 | -7426.00 USD | 0.0% |
| 2006 Q1 | 864.00 USD | -83.58% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | -100.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | 5263.00 USD | 25.82% |
| 2005 Q3 | 4183.00 USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -778.119% |
| BrainsWay Ltd. | 23.09 Million USD | 3.027% |
| Cerus Corporation | 86.4 Million USD | 74.083% |
| Envoy Medical, Inc. | -473 Thousand USD | 4834.043% |
| electroCore, Inc. | 13.22 Million USD | -69.303% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -36608.234% |
| IceCure Medical Ltd | 1.3 Million USD | -1622.463% |
| Inogen, Inc. | 126.69 Million USD | 82.327% |
| OrthoPediatrics Corp. | 111.25 Million USD | 79.873% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 470.116% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 47404.426% |
| MaxCyte, Inc. | 36.54 Million USD | 38.729% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -4804.97% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -26224.974% |
| Orthofix Medical Inc. | 486.27 Million USD | 95.395% |
| PAVmed Inc | -3.96 Million USD | 664.315% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 508.241% |
| RxSight, Inc. | 53.76 Million USD | 58.352% |
| Sight Sciences, Inc. | 69.17 Million USD | 67.63% |
| SI-BONE, Inc. | 109.42 Million USD | 79.536% |
| TELA Bio, Inc. | 40.11 Million USD | 44.176% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 85.262% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -170.729% |
| Acutus Medical, Inc. | -3.13 Million USD | 813.804% |
| Talis Biomedical Corporation | 371 Thousand USD | -5935.586% |
| Spectral AI, Inc. | 7.88 Million USD | -184.163% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 439.685% |
| CVRx, Inc. | 33.03 Million USD | 32.225% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -2927.889% |
| Bioventus Inc. | 328.19 Million USD | 93.177% |
| Venus Concept Inc. | 52.16 Million USD | 57.076% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -40.777% |
| LivaNova PLC | 771.25 Million USD | 97.097% |
| 908 Devices Inc. | 25.32 Million USD | 11.571% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 92.781% |
| Nemaura Medical Inc. | -1.47 Million USD | 1616.672% |
| NeuroPace, Inc. | 48.12 Million USD | 53.468% |
| LENSAR, Inc. | 21.1 Million USD | -6.088% |
| Apyx Medical Corporation | 14.12 Million USD | -58.561% |
| Cutera, Inc. | 41.49 Million USD | 46.036% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -21.294% |
| BioSig Technologies, Inc. | 18 Thousand USD | -124300.128% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 78.279% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -64.478% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 97.479% |
| Axonics, Inc. | 274.55 Million USD | 91.844% |
| Outset Medical, Inc. | 29 Million USD | 22.786% |
| IRIDEX Corporation | 21.8 Million USD | -2.683% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 68.484% |
| IRadimed Corporation | 50.15 Million USD | 55.357% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -7702.099% |
| INVO Bioscience, Inc. | 1.08 Million USD | -1961.619% |
| Telesis Bio, Inc. | 16.95 Million USD | -32.106% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 80.146% |
| Varex Imaging Corporation | 256.9 Million USD | 91.284% |
| Quipt Home Medical Corp. | 163.84 Million USD | 86.333% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 5615.277% |
| Pulmonx Corporation | 50.75 Million USD | 55.88% |
| Dynatronics Corporation | 7.63 Million USD | -193.282% |
| Modular Medical, Inc. | -768 Thousand USD | 3015.628% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -303.605% |
| Semler Scientific, Inc. | 61.2 Million USD | 63.412% |
| InMode Ltd. | 411.34 Million USD | 94.556% |
| Bruker Corporation | 1.51 Billion USD | 98.524% |
| DexCom, Inc. | 2.28 Billion USD | 99.022% |
| Align Technology, Inc. | 2.71 Billion USD | 99.176% |
| Viveve Medical, Inc. | 620 Thousand USD | -3511.617% |
| ZimVie Inc. | 290.38 Million USD | 92.289% |
| Movano Inc. | -158 Thousand USD | 14272.166% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 79.537% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -26224.974% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 93.91% |
| Profound Medical Corp. | 4.51 Million USD | -396.055% |
| Insulet Corporation | 1.15 Billion USD | 98.069% |
| enVVeno Medical Corporation | -546 Thousand USD | 4201.103% |
| Surmodics, Inc. | 93.05 Million USD | 75.936% |
| iCAD, Inc. | 14.53 Million USD | -54.045% |
| Nuwellis, Inc. | 4.98 Million USD | -349.368% |
| Biotricity, Inc. | 8.35 Million USD | -167.966% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 93.251% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 6336.342% |
| InspireMD, Inc. | 1.8 Million USD | -1139.182% |
| PAVmed Inc. | -3.96 Million USD | 664.315% |
| BIOLASE, Inc. | 16.72 Million USD | -33.892% |
| Beyond Air, Inc. | -1.3 Million USD | 1813.238% |
| FONAR Corporation | 45.14 Million USD | 50.394% |
| AxoGen, Inc. | 127.87 Million USD | 82.489% |
| Vivani Medical, Inc. | -357 Thousand USD | 6372.275% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 88.525% |
| Inari Medical, Inc. | 434.56 Million USD | 94.847% |
| UFP Technologies, Inc. | 112.22 Million USD | 80.047% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -178764.31% |
| Tenon Medical, Inc. | 1.24 Million USD | -1704.353% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 27744.473% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -752.351% |
| AdaptHealth Corp. | 479.56 Million USD | 95.331% |
| Sintx Technologies, Inc. | 1.84 Million USD | -1114.977% |
| NanoVibronix, Inc. | 1.53 Million USD | -1356.866% |
| Quanterix Corporation | 70.64 Million USD | 68.304% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 5615.277% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -59.26% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 57.575% |
| TransMedics Group, Inc. | 154.09 Million USD | 85.469% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -402.853% |
| NeuroMetrix, Inc. | 3.94 Million USD | -467.258% |
| Hyperfine, Inc. | 4.75 Million USD | -370.717% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 79.068% |
| Biomerica, Inc. | 611 Thousand USD | -3564.816% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 46.286% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 2967.262% |
| Silk Road Medical, Inc | 127.08 Million USD | 82.38% |